Associated Papers
Clinical and Genomic Characteristics of Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Following Progression on Cyclin-Dependent Kinase 4 and 6 Inhibitors.
Rao X et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2023
Abnormally Methylated FMR1 in Absence of a Detectable Full Mutation in a U.S.A Patient Cohort Referred for Fragile X Testing.
Hensel CH et al.
Scientific Reports, 2019
Select a paper to view details